The pharmaceutical community is intrigued by retatrutide, a novel dual GIP and GLP-1 target that’s showing impressive results in clinical trials . This medication works by imitating natural hormones to affect appetite and increase feelings of satisfaction , ultimately leading noticeable weight lo